# FDA Inspection 676458 - Taizhou Taifa Pharmaceuticals Co., Ltd. - August 05, 2010

Source: https://www.keypedia.com/records/fda_inspections/taizhou-taifa-pharmaceuticals-co-ltd/02bce8a4-4e93-4551-b9d6-581729554a5d
Source feed: FDA_Inspections

> FDA Inspection 676458 for Taizhou Taifa Pharmaceuticals Co., Ltd. on August 05, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 676458
- Company Name: Taizhou Taifa Pharmaceuticals Co., Ltd.
- Inspection Date: 2010-08-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1094254 - 2019-05-15](https://www.keypedia.com/records/fda_inspections/taizhou-taifa-pharmaceuticals-co-ltd/36b71010-c8c3-4145-b1ac-4570c589c2a9)
- [FDA Inspection 990107 - 2016-09-15](https://www.keypedia.com/records/fda_inspections/taizhou-taifa-pharmaceuticals-co-ltd/f3c2b6ae-a131-4b64-8e48-f13e092e8200)
- [FDA Inspection 883252 - 2014-05-15](https://www.keypedia.com/records/fda_inspections/taizhou-taifa-pharmaceuticals-co-ltd/aad19797-f78c-4368-a17b-7894b5c0d99f)

Company: https://www.keypedia.com/companies/taizhou-taifa-pharmaceuticals-co-ltd/ffb9eee9-0ca2-4c62-a2ec-bb973a5cc18c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c